RT @RCarhartHarris: Is this the first DB-RCT of LSD microdosing? https://t.co/crPkr7g2GN
Happy to announce the publication of our phase 1 results of low dose LSD in older healthy adults. @EleusisLtd https://t.co/FGFRC009RO
RT @DDNewsOnline: .@EleusisLtd touts safety, tolerability & PK/PD of low-dose #LSD in healthy older subjects in Ph1 #clinicaltrials Sees p…
RT @ManojDoss: Once again, microdosing not found to enhance cognition on multiple tasks in a population that may have especially benefited…
"These findings support the feasibility of using intermittent low dose #LSD treatment in clinical therapeutic strategies & open the door for larger studies designed to evaluate anxiolytic, antidepressant, pro-cognitive & anti-inflammatory efficacy"
RT @DDNewsOnline: .@EleusisLtd touts safety, tolerability & PK/PD of low-dose #LSD in healthy older subjects in Ph1 #clinicaltrials Sees p…
RT @RCarhartHarris: Is this the first DB-RCT of LSD microdosing? https://t.co/crPkr7g2GN
Once again, microdosing not found to enhance cognition on multiple tasks in a population that may have especially benefited from cognitive enhancement: https://t.co/wMtLvAcoht Nice work @neiloufar.
RT @DDNewsOnline: .@EleusisLtd touts safety, tolerability & PK/PD of low-dose #LSD in healthy older subjects in Ph1 #clinicaltrials Sees p…
RT @arnthorjon: Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (#LSD) in healthy older…
RT @RCarhartHarris: Is this the first DB-RCT of LSD microdosing? https://t.co/crPkr7g2GN
RT @RCarhartHarris: Is this the first DB-RCT of LSD microdosing? https://t.co/crPkr7g2GN
RT @RCarhartHarris: Is this the first DB-RCT of LSD microdosing? https://t.co/crPkr7g2GN
RT @RCarhartHarris: Is this the first DB-RCT of LSD microdosing? https://t.co/crPkr7g2GN
Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (#LSD) in healthy older volunteers https://t.co/eo8Yeaf11X
Is this the first DB-RCT of LSD microdosing?